Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Propranolol Treatment in Newborns With Retinopathy of Prematurity:a Prospective Cohort Study

NCT03038295 is registered in ClinicalTrials.gov with Guangdong Women and Children Hospital as lead sponsor.

NCT NCT03038295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Propranolol Treatment in Newborns With Retinopathy of Prematurity:a Prospective Cohort Study
Lead sponsor
Guangdong Women and Children Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2017
Completion date
December 31, 2019
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity